PYM Phytopharm

TIDMIXI

IXICO plc

21 January 2016

IXICO's MyBrainBook wins Regional Business Award for Partnership with the NHS

21 January 2016, IXICO plc (Ticker: IXI) ('IXICO' or the 'Company'), the brain health company, is pleased to announce that MyBrainBook(R), its digital support platform for people with dementia and their carers, has won the Partnership with the NHS category in the SEHTA Regional Healthcare Business Awards. The award was announced at the Kent Surrey Sussex Academic Health Science Network Expo and Awards 2016.

MyBrainBook(R) has been developed in collaboration with the Health Innovation Network (Academic Health Science Network for South London), Mental Health Trusts, community care providers and 3(rd) sector partners across South London. It has been designed with input from patients, their carers and professionals to promote self-care and prevent escalating need for people living with dementia. It is currently being evaluated by NHS patients with the support of trained facilitators. Further information including a video introducing MyBrainBook(R) is available at www.mybrainbook.com

Professor Derek Hill, Chief Executive of IXICO, commented:

"We are delighted to have received this award for our work in partnership with the NHS as IXICO is committed to improving the lives of people with dementia and their families. MyBrainBook(R) is a key part of IXICO's evolving digital healthcare platform to support healthcare professionals, patients, carers and organizations developing new treatments. From the outset, we have been working with potential users to develop MyBrainBook(R) to ensure that it is both relevant and user-friendly."

Enquiries:

 
 IXICO plc                       +44 20 3763 7499 
 Derek Hill, CEO 
 Susan Lowther, CFO 
 Charles Spicer, VP Corporate 
  Development 
 
 Peel Hunt LLP (Nominated 
  Adviser and Broker)            +44 20 7418 8900 
 James Steel / Oliver Jackson 
 
 
 Daniel Stewart & Company 
  (Joint Broker)                 +44 207 776 6550 
 Martin Lampshire / David 
  Coffman 
 
 
 FTI Consulting Limited 
  (Investor Relations)           +44 20 3727 1000 
 Simon Conway / Mo Noonan 
  / Matthew Moss 
 

Notes to Editors

About IXICO

IXICO's innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions. In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes. In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Multiple Sclerosis, behavioural health, child and adolescent mental health.

More information is available on www.ixico.com

About MyBrainBook(R)

MyBrainBook(R) has been developed by IXICO as a new way of providing the best care to people with dementia. MyBrainBook is a digital hub which gives people with dementia and their carers the ability to build a personal profile and action plan with information they provide about the important aspects of their life. Restricted access is available to health and social care workers to ensure the appropriate support can be provided when needed.

More information is available on www.mybrainbook.com

About SEHTA

South East Health Technologies Alliance (SEHTA) is one of the largest healthcare technology networking organisations in the UK with 1,300 members from 20 different countries and a database of more than 7,000 contacts spanning academia, industry, clinicians, the NHS and wider health and social care providers, local government, policy-makers, research councils and funding bodies.

More information is available on www.sehta.co.uk

About the Health Innovation Network

The Health Innovation Network is the Academic Health Science Network (AHSN) for South London, one of 15 AHSNs across England. We connect academics, NHS commissioners and providers, local authorities, patients and patient groups, and industry in order to accelerate the spread and adoption of innovations and best practice, using evidence-based research across large populations. Working as catalysts of change across health and social care economies, we enable health improvements and economic growth.

More information is available on www.hin-southlondon.org

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAEAAFEAAFKEAF

(END) Dow Jones Newswires

January 21, 2016 02:00 ET (07:00 GMT)

Phytopharm (LSE:PYM)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Phytopharm (LSE:PYM)
Historical Stock Chart
Von Dez 2023 bis Dez 2024